The Journal of Korean Diabetes

Search

Page Path

HOME
Search

Opinion

Dipeptidyl Peptidase-4 억제제와 Sodium Glucose Cotransporter 2 억제제의 새로운 안전성 이슈: 어떻게 해석하고 진료현장에 적용할 것인가?: Nam Hoon Kim, Sin Gon Kim; J Korean Diabetes. 2017;18(3):135-140. Published online October 12, 2017; DOI: https://doi.org/10.4093/jkd.2017.18.3.135

실제 임상에서 처방 패턴이 변할 것인가?: Hyuk Sang Kwon; J Korean Diabetes. 2016;17(4):225-232. Published online December 30, 2016; DOI: https://doi.org/10.4093/jkd.2016.17.4.225

Focused Issues

SGLT2 억제제의 부작용: Won Jin Kim, Sang Soo Kim; J Korean Diabetes. 2014;15(3):158-162. Published online September 30, 2014; DOI: https://doi.org/10.4093/jkd.2014.15.3.158
Cited By 5

DPP-4 억제제의 임상효과: Sang Ah Lee; J Korean Diabetes. 2013;14(3):128-132. Published online September 30, 2013; DOI: https://doi.org/10.4093/jkd.2013.14.3.128

Original Articles

메트포르민/글리벤클라미드 복합제의 유효성 및 안전성: 백나나, 이우제, 이병두, 고경수; J Korean Diabetes. 2008;9(3):241-247.

Volume 25, No. 1

The Journal of
Korean Diabetes

Print ISSN: 2233-7431
Online ISSN: 2714-0547

MOST VIEWED

3,793	Use of Dual-Energy X-ray Absorptiometry for Body Composition in Chronic Disease Management
4,352	Recent Advances in Anti-Obesity Drugs
1,178	Diabetes and Dietary Fats
2,168	Revisiting the Diabetes Crisis in Korea: Call for Urgent Action
1,066	2023 Clinical Practice Guidelines for Diabetes

Editorial Office: 101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea
Tel: +82-2-714-9064 Fax: +82-2-714-9084 E-mail: diabetes@kams.or.kr

Copyright © 2024 by Korean Diabetes Association. All rights reserved.